BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 3948140)

  • 1. Interferon therapy for the treatment of renal cancer.
    Neidhart JA
    Cancer; 1986 Apr; 57(8 Suppl):1696-9. PubMed ID: 3948140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon therapy for renal cell carcinoma.
    Muss HB
    Semin Oncol; 1987 Jun; 14(2 Suppl 2):36-42. PubMed ID: 3589703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapy of renal cell carcinoma. 3. Interferon therapy].
    Kobayashi M; Imai K; Kiren H; Nakai K; Saruki K; Umeyama T; Ito Y; Yamanaka H; Makino T; Machida M
    Hinyokika Kiyo; 1987 Apr; 33(4):508-14. PubMed ID: 3618421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic options in renal-cell carcinoma.
    Krown SE
    Semin Oncol; 1985 Dec; 12(4 Suppl 5):13-7. PubMed ID: 2417331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II results with recombinant interferons: renal cell carcinoma and malignant melanoma.
    Kuzmits R; Kokoschka EM; Micksche M; Ludwig H; Flener R
    Oncology; 1985; 42 Suppl 1():26-32. PubMed ID: 4080298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of interferons in the therapy of metastatic renal cell carcinoma.
    Quesada JR
    Urology; 1989 Oct; 34(4 Suppl):80-3; discussion 87-96. PubMed ID: 2678687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of recombinant alpha-interferon on advanced renal cell carcinoma].
    Isaka S; Okano T; Akimoto S; Shimazaki J; Murakami S; Igarashi T; Kitamura Y; Yamaguchi K; Kataumi S; Ohtsuka K
    Hinyokika Kiyo; 1985 Dec; 31(12):2209-14. PubMed ID: 3832921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II trial of interferon-beta-serine in metastatic renal cell carcinoma.
    Kinney P; Triozzi P; Young D; Drago J; Behrens B; Wise H; Rinehart JJ
    J Clin Oncol; 1990 May; 8(5):881-5. PubMed ID: 2332772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon therapy of metastatic renal cell cancer.
    Muss HB
    Semin Surg Oncol; 1988; 4(3):199-203. PubMed ID: 3055163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of interferon and interleukin-2 in the immunotherapeutic approach to renal cell carcinoma.
    Figlin RA; Abi-Aad AS; Belldegrun A; deKernion JB
    Semin Oncol; 1991 Oct; 18(5 Suppl 7):102-7. PubMed ID: 1719641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Medical treatment of metastatic cancer of the kidney with a combination of vinblastine and recombinant interferon alpha IIa. Result of a phase I-II trial].
    Jacqmin D; Bergerat JP; Dufour P; Bollack C; Prévot G; Jurascheck F; Bailly G; Degaris S; Oberling F
    J Urol (Paris); 1987; 93(8):463-6. PubMed ID: 3440838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of biological response modifiers for management of renal cell carcinoma.
    Wilkinson M; Aronson F
    Urol Int; 1991; 46(3):304-8. PubMed ID: 1926644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of renal carcinoma with alpha-interferon: biological bases and clinical results].
    Cetto GL; Feruglio C; Franceschi T; Semenzato G
    Ann Ital Med Int; 1990; 5(3 Pt 1):205-15. PubMed ID: 2288823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon therapy for metastatic renal cell carcinoma.
    Swanson DA; Quesada JR
    Semin Surg Oncol; 1988; 4(3):174-7. PubMed ID: 3142007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase IA trial of sequential administration recombinant DNA-produced interferons: combination recombinant interferon gamma and recombinant interferon alfa in patients with metastatic renal cell carcinoma.
    Ernstoff MS; Nair S; Bahnson RR; Miketic LM; Banner B; Gooding W; Day R; Whiteside T; Hakala T; Kirkwood JM
    J Clin Oncol; 1990 Oct; 8(10):1637-49. PubMed ID: 2120392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant interferon alpha and gamma in combination as treatment for metastatic renal cell carcinoma.
    Quesada JR; Evans L; Saks SR; Gutterman JU
    J Biol Response Mod; 1988 Jun; 7(3):234-9. PubMed ID: 3134511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Phase II trial of treatment of metastatic renal adenocarcinoma with recombinant leukocyte interferon (rDNA IFN-alpha 2)].
    Dorval T; Palangie T; Garcia-Giralt E; Jouve M; Bretaudeau B; Falcoff F; Coninx P; Schwab D; Pouillart P
    Bull Cancer; 1985; 72(5):470-1. PubMed ID: 4074917
    [No Abstract]   [Full Text] [Related]  

  • 18. Renal cell carcinoma: treatment with interferon.
    Grosh WW
    Compr Ther; 1987 Jun; 13(6):34-9. PubMed ID: 2438082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II study of interferon alfa-2a, recombinant (Roferon-A) in metastatic renal cell carcinoma.
    Buzaid AC; Robertone A; Kisala C; Salmon SE
    J Clin Oncol; 1987 Jul; 5(7):1083-9. PubMed ID: 3598612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of metastatic kidney cancer with recombinant alpha-2 or gamma interferon. Results of 2 clinical phase II and III studies].
    Otto U; Schneider A; Denkhaus H; Conrad S
    Onkologie; 1988 Aug; 11(4):185-91. PubMed ID: 3141856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.